Contract facts
FederalNo full NAICS 325413 intel page yet. Browse NAICS intelligence
ORDERING ARK FENTANYL II REAGENT KITS FOR THE FY26 WITH A POP OF 19 DEC 2025 - 30 SEPTEMBER 2026 CUSTOMER: AFDTL BASE CONTRACT: N6264523D5013 ALL TERMS AND CONDITIONS FROM THE BASE CONTRACT APPLY TO THIS DELIVERY ORDER. is a federal award for Fa3016 502 Cons Cl held by Siemens Healthcare Diagnostics Inc. Estimated value $245K ($245K obligated). Current period of performance ends Sep 8, 2026. Place of performance: LACKLAND AFB TX.
ORDERING ARK FENTANYL II REAGENT KITS FOR THE FY26 WITH A POP OF 19 DEC 2025 - 30 SEPTEMBER 2026 CUSTOMER: AFDTL BASE CONTRACT: N6264523D5013 ALL TERMS AND CONDITIONS FROM THE BASE CONTRACT APPLY TO THIS DELIVERY ORDER.
Recompete timing
PublicCurrent PoP ends Sep 8, 2026 (18 days remaining). Agencies typically plan 12–18 months ahead — at 0.6 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordSiemens Healthcare Diagnostics Inc — $112.7M obligated across 924 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract FA301626F0044?
FA301626F0044 (Ordering ARK fentanyl II reagent KITS) is a Fa3016 502 Cons Cl award with a potential value of $245K, currently held by Siemens Healthcare Diagnostics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is FA3016-26-F-0044?
FA3016-26-F-0044 is the dashed form of PIID FA301626F0044 (Ordering ARK fentanyl II reagent KITS), held by Siemens Healthcare Diagnostics Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded FA301626F0044?
Fa3016 502 Cons Cl awarded FA301626F0044 to Siemens Healthcare Diagnostics Inc (potential $245K).
Who is the incumbent on FA301626F0044?
Siemens Healthcare Diagnostics Inc is the incumbent with $112.7M across 924 related awards in SCOUT’s public footprint. The current period of performance ends Sep 8, 2026.
When does Siemens Healthcare Diagnostics Inc’s FA301626F0044 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 8, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.